| Literature DB >> 32102823 |
Junsheng Chen1,2, Yubin Cao2,3, Meijie Wang1,2, Xueqi Gan1,2, Chunjie Li4,3, Haiyang Yu5,2.
Abstract
OBJECTIVES: To analyse the relationship between demographic characteristics, reporting quality and final publication rate of conference abstracts of prosthodontic randomised-controlled trials (RCTs) presented at International Association for Dental Research (IADR) general sessions (2002-2015).Entities:
Keywords: qualitative research; quality in health care; statistics & research methods
Year: 2020 PMID: 32102823 PMCID: PMC7045257 DOI: 10.1136/bmjopen-2019-034635
Source DB: PubMed Journal: BMJ Open ISSN: 2044-6055 Impact factor: 2.692
Figure 1Final publication of conference abstracts of prosthodontic RCTs presented at IADR general sessions (2002–2015). (A) Cumulative publication rate. The proportion of unpublished conference abstracts decreased with time. (B) Journals published on. Only journals with more than three publications were listed in the figure. The journals were ranked from the left by the higher number of published abstracts. IADR, International Association for Dental Research; RCT, randomised-controlled trial.
Figure 2The number of abstracts and publication rate of prosthodontic RCTs presented at IADR general sessions of each year (2002–2015). The histogram showed the number of published (light red) and unpublished abstracts (deep red) in each year (the number was labelled on the left). The line chart showed the publication rates (black point) in each year (the number was labelled on the right). IADR, International Association for Dental Research; RCT, randomised-controlled trial.
Figure 3The origin distribution of prosthodontic RCTs presented at IADR general sessions (2002–2015). The shade of red colour correlated with the number of abstracts originated from the country while blank indicated no abstracts. The pie chart showed the overall publication rate of abstracts in the continent. The size of countries was not proportional to the national territorial area. And due to the limited number of abstracts, Asia and Australia were illustrated together. IADR, International Association for Dental Research; RCT, randomised-controlled trial.
The relationship between characteristics and publication rate of prosthodontic RCTs presented at IADR general sessions of each year (2002–2015)
| Characteristics | Classification | Abstracts | Publication rate (%) | OR (95% CI) | P value | |
| Number | Ratio (%) | |||||
| Presentation type | Poster | 220 | 64.71 | 38.18 | 1 | |
| Oral | 120 | 35.29 | 52.5 | 1.79 (1.14 to 2.81) | 0.01 | |
| Exact p value | No | 110 | 32.35 | 40 | 1 | |
| Yes | 230 | 67.65 | 44.78 | 1.22 (0.77 to 1.93) | 0.41 | |
| Centre | Single centre | 320 | 94.12 | 41.56 | 1 | |
| Multicentre | 20 | 5.88 | 70 | 3.28 (1.23 to 8.76) | 0.02 | |
| Type of institution | Universities | 332 | 97.65 | 43.37 | 1 | |
| Other institutions | 8 | 2.35 | 37.5 | 0.78 (0.18 to 3.33) | 0.74 | |
| Overall conclusion | Positive | 188 | 55.29 | 45.21 | 1 | |
| Negative | 46 | 13.53 | 39.13 | 0.78 (0.40 to 1.50) | 0.46 | |
| Neutral | 106 | 31.18 | 41.51 | 0.86 (0.53 to 1.39) | 0.54 | |
| Subspecialty | Fixed prosthodontics | 32 | 9.41 | 31.25 | 1 | |
| Removable partial dentures | 11 | 3.24 | 45.45 | 1.83 (0.45 to 7.45) | 0.4 | |
| Complete denture and overdenture | 60 | 17.65 | 61.67 | 3.54 (1.42 to 8.80) | 0.01 | |
| Implant-based prosthetics | 46 | 13.53 | 52.17 | 2.4 (0.93 to 2.18) | 0.07 | |
| Dental composites and adhesives | 114 | 33.53 | 32.46 | 1.06 (0.45 to 2.46) | 0.9 | |
| Temporomandibular disorders | 44 | 12.94 | 52.27 | 2.41 (0.96 to 6.25) | 0.07 | |
| Others | 33 | 9.71 | 33.33 | 1.1 (0.39 to 3.11) | 0.86 | |
IADR, International Association for Dental Research; RCT, randomised-controlled trial.
The relationship between reporting quality and final publication rate of prosthodontic RCTs presented at IADR general sessions of each year (2002–2015)
| Items | Description | Number of published abstracts (%) | Number of unpublished abstracts (%) | OR (95% CI) | P value |
| Title | Identification of the study as randomised. | 21 (14.29) | 24 (12.4) | 1.15 (0.67 to 1.98) | 0.62 |
| Trial design | Description of the trial design | 31 (21.09) | 34 (17.6) | 1.2 (0.77 to 1.85) | 0.42 |
| Methods | |||||
| Participant | Eligibility criteria for participants and the settings where the data were collected | 16 (10.88) | 13 (6.74) | 1.62 (0.80 to 3.25) | 0.18 |
| Eligibility criteria | 127 (86.39) | 131 (67.9) | 1.27 (1.13 to 1.43) | <0.0001 | |
| Settings | 16 (10.88) | 17 (8.81) | 1.24 (0.65 to 2.36) | 0.52 | |
| Interventions | Interventions intended for each group | 147 (100.00) | 193 (100.00) | 1 (0.99 to 1.01) | 1 |
| Objective | Specific objective or hypothesis | 147 (100.00) | 193 (100.00) | 1 (0.99 to 1.01) | 1 |
| Outcome | Clearly defined primary outcome for this report | 6 (4.08) | 12 (6.22) | 0.66 (0.25 to 1.71) | 0.39 |
| Randomisation | How participants were allocated to interventions | 1 (0.68) | 1 (0.52) | 1.31 (0.08 to 20.82) | 0.85 |
| Random assignment | 140 (95.24) | 167 (86.53) | 1.1 (1.03 to 1.18) | 0.005 | |
| Sequence generation | 5 (3.40) | 4 (2.07) | 1.64 (0.45 to 6.00) | 0.45 | |
| Allocation concealment | 1 (0.68) | 3 (1.55) | 0.44 (0.05 to 4.16) | 0.47 | |
| Blinding (masking) | Whether or not participants, caregivers and those assessing the outcomes were blinded to group assignment | 7 (4.76) | 18 (9.33) | 0.51 (0.22 to 1.19) | 0.12 |
| Only described single-blind or double-blind | 21 (14.29) | 22 (11.40) | 1.25 (0.72 to 2.19) | 0.43 | |
| Results | |||||
| Numbers randomised | Number of participants randomly assigned to each group | 146 (99.32) | 191 (98.96) | 1 (0.98 to 1.02) | 0.72 |
| Only definite total sample size | 67 (45.58) | 95 (44.04) | 0.93 (0.74 to 1.16) | 0.51 | |
| Recruitment | Trial status | 0 (0.00) | 4 (2.07) | 0.15 (0.01 to 2.68) | 0.2 |
| Numbers | Number of participants analysed in each group | 38 (25.85) | 79 (40.93) | 0.63 (0.46 to 0.87) | 0.005 |
| analysed | Intention-to-treat analysis | 3 (2.04) | 0 (0.00) | 9.18 (0.48 to 176.27) | 0.14 |
| Outcome | For the primary outcome, a result for each group and the estimated effect size and its precision | 10 (6.80) | 6 (3.11) | 2.19 (0.81 to 5.88) | 0.12 |
| Primary outcome result for each group | 141 (95.92) | 160 (82.90) | 1.16 (1.08 to 1.24) | <0.0001 | |
| Estimated effect size and its precision | 63 (42.86) | 125 (64.77) | 0.66 (0.53 to 0.82) | 0.0002 | |
| Precision of the estimate | 10 (6.80) | 6 (3.11) | 2.19 (0.81 to 5.88) | 0.12 | |
| Harms | Important adverse events or side effects | 11 (7.48) | 5 (2.59) | 2.89 (1.03 to 8.13) | 0.04 |
| Conclusions | General interpretation of the results | 147 (100.00) | 193 (100.00) | 1 (0.99 to 1.01) | 1 |
| Trial registration | Registration number and name of trial register | 10 (6.80) | 3 (1.55) | 4.38 (1.23 to 15.62) | 0.02 |
| Funding | Source of funding | 37 (25.17) | 74 (38.34) | 0.66 (0.47 to 0.91) | 0.01 |
IADR, International Association for Dental Research; RCT, randomised-controlled trial.